Literature DB >> 864290

Pharmacologic factors associated with gentamicin nephrotoxicity in rabbits.

P T Frame, J P Phair, C Watanakunakorn, T W Bannister.   

Abstract

Nine rabbits were given subcutaneous doses of 7.5 mg of gentamicin/kg every 24 hr, and nine were given 2.5 mg of gentamicin/kg every 8 hr for three weeks or longer. Renal function was evaluated by monitoring of the concentration of creatinine in serum and the rate of clearance of gentamicin from serum. In the animals receiving the 8-hr divided dosage, a deterioration of renal function as early as day 7 was demonstrated by the rate of clearance of gentamicin, and deterioration by day 21 was evidenced by the concentration of creatinine in serum; the renal function of the animals receiving the single daily dose was unchanged. There was no relationship between peak or trough concentrations of gentamicin in serum and the development of nephrotoxicity. The animals receiving the 8-hr dosages had a significantly longer daily duration of exposure to concentrations of greater than or equal to 0.1, greater than or equal to 1.0, greater than or equal to 2.0, and greater than or equal to 3.0 microng of gentamicin/ml in serum than did animals receiving the daily dosage.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 864290     DOI: 10.1093/infdis/135.6.952

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  17 in total

Review 1.  Once-daily aminoglycoside therapy.

Authors:  D N Gilbert
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

2.  Nephrocalcinosis in preterm babies.

Authors:  A Narendra; M P White; H A Rolton; Z I Alloub; G Wilkinson; J H McColl; J Beattie
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-11       Impact factor: 5.747

3.  Once-daily dosing of aminoglycosides.

Authors:  J Blaser; C König
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-12       Impact factor: 3.267

Review 4.  Aminoglycoside dosage regimens. Is once a day enough?

Authors:  W N Hustinx; I M Hoepelman
Journal:  Clin Pharmacokinet       Date:  1993-12       Impact factor: 6.447

Review 5.  Once-daily aminoglycoside administration: new strategies for an old drug.

Authors:  J M Kovarik; I M Hoepelman; J Verhoef
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-09       Impact factor: 3.267

6.  Impact of the dosage schedule on the efficacy of ceftazidime, gentamicin and ciprofloxacin in Klebsiella pneumoniae pneumonia and septicemia in leukopenic rats.

Authors:  R Roosendaal; I A Bakker-Woudenberg; M van den Berghe-van Raffe; J C Vink-van den Berg; B M Michel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-10       Impact factor: 3.267

Review 7.  Why monitor serum levels of gentamicin?

Authors:  M Barza; M Lauermann
Journal:  Clin Pharmacokinet       Date:  1978 May-Jun       Impact factor: 6.447

8.  Gentamicin, netilmicin, dibekacin, and amikacin nephrotoxicity and its relationship to tubular reabsorption in rabbits.

Authors:  N Brion; J Barge; I Godefroy; F Dromer; C Dubois; A Contrepois; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1984-02       Impact factor: 5.191

9.  Increased renal DNA synthesis in vivo after administration of low doses of gentamicin to rats.

Authors:  G Laurent; P Maldague; M B Carlier; P M Tulkens
Journal:  Antimicrob Agents Chemother       Date:  1983-10       Impact factor: 5.191

Review 10.  Impact of dosage schedule of antibiotics on the treatment of serious infections.

Authors:  I A Bakker-Woudenberg; R Roosendaal
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.